FDA issued guidance on April 10, 2025 to phase out animal trials in favor of organoids and organ-on-a-chip systems. This pivotal move was swiftly followed by National Institutes of Health (NIH) on ...
Cancer research laboratory tests can now be done using micro-physiological systems mimicking human physiology, allowing ...
Organoids, as three-dimensional, self-organizing tissue models, have become indispensable tools in fields such as oncology, infectious disease, developmental biology, and regenerative medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results